Search Results - "Mara, Arlind B."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes by Rawat, Kavita, Tewari, Anita, Li, Xin, Mara, Arlind B, King, William T, Gibbings, Sophie L, Nnam, Chinaza F, Kolling, Fred W, Lambrecht, Bart N, Jakubzick, Claudia V

    Published in The Journal of experimental medicine (05-06-2023)
    “…Dendritic cells (DCs) and monocytes capture, transport, and present antigen to cognate T cells in the draining lymph nodes (LNs) in a CCR7-dependent manner…”
    Get full text
    Journal Article
  2. 2

    Rationally designed Mycoplasma gallisepticum vaccine using a recombinant subunit approach by Miller, Jeremy M., Ozyck, Rosemary Grace, Pagano, Patrick L., Hernandez, Esmeralda F., Davis, Megan E., Karam, Anton Q., Malek, Jessica B., Mara, Arlind B., Tulman, Edan R., Szczepanek, Steven M., Geary, Steven J.

    Published in npj vaccines (28-09-2024)
    “…Mycoplasma gallisepticum (MG) is an avian respiratory pathogen causing significant global economic losses to the poultry industries. Current live-attenuated…”
    Get full text
    Journal Article
  3. 3

    Vaccination with Mycoplasma pneumoniae membrane lipoproteins induces IL-17A driven neutrophilia that mediates Vaccine-Enhanced Disease by Mara, Arlind B., Gavitt, Tyler D., Tulman, Edan R., Miller, Jeremy M., He, Wu, Reinhardt, Emily M., Ozyck, R. Grace, Goodridge, Meagan L., Silbart, Lawrence K., Szczepanek, Steven M., Geary, Steven J.

    Published in npj vaccines (29-07-2022)
    “…Bacterial lipoproteins are an often-underappreciated class of microbe-associated molecular patterns with potent immunomodulatory activity. We previously…”
    Get full text
    Journal Article
  4. 4

    Immunogenicity Threshold in Allogeneic Cells Impacts CTL Response to Nondominant Congenic Antigens by Rawat, Kavita, Mara, Arlind B, King, William T, Nnam, Chinaza F, Jakubzick, Claudia V

    Published in The Journal of immunology (1950) (01-12-2023)
    “…Transplantation and cancer expose the immune system to neoantigens, including immunogenic (dominant and subdominant) and nonimmunogenic Ags with varying…”
    Get full text
    Journal Article
  5. 5

    Coordinated chemokine expression defines macrophage subsets across tissues by Li, Xin, Mara, Arlind B., Musial, Shawn C., Kolling, Fred W., Gibbings, Sophie L., Gerebtsov, Nikita, Jakubzick, Claudia V.

    Published in Nature immunology (01-06-2024)
    “…Lung-resident macrophages, which include alveolar macrophages and interstitial macrophages (IMs), exhibit a high degree of diversity, generally attributed to…”
    Get full text
    Journal Article
  6. 6

    Transdermal microneedles for the programmable burst release of multiple vaccine payloads by Tran, Khanh T. M., Gavitt, Tyler D., Farrell, Nicholas J., Curry, Eli J., Mara, Arlind B., Patel, Avi, Brown, Lindsey, Kilpatrick, Shawn, Piotrowska, Roxana, Mishra, Neha, Szczepanek, Steven M., Nguyen, Thanh D.

    Published in Nature biomedical engineering (01-09-2021)
    “…Repeated bolus injections are associated with higher costs and poor compliance and can hinder the implementation of global immunization campaigns. Here, we…”
    Get full text
    Journal Article
  7. 7

    A GATA3 Targeting Nucleic Acid Nanocapsule for In Vivo Gene Regulation in Asthma by Gavitt, Tyler D., Hartmann, Alyssa K., Sawant, Shraddha S., Mara, Arlind B., Szczepanek, Steven M., Rouge, Jessica L.

    Published in ACS nano (27-07-2021)
    “…Allergic asthma is one of the leading chronic lung diseases of both children and adults worldwide, resulting in significant morbidity and mortality in affected…”
    Get full text
    Journal Article
  8. 8

    Natural antibodies drive type 2 immunity in response to damage associated molecular patterns by Mara, Arlind B, Rawat, Kavita, King, William T, Jakubzick, Claudia V

    Published in JCI insight (12-03-2024)
    “…Allergic Airway Disease (AAD) is an example of type 2 inflammation which leads to chronic airway eosinophilia controlled by CD4 Th2 cells. Inflammation is…”
    Get full text
    Journal Article
  9. 9

    B cells oppose Mycoplasmapneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs by Gavitt, Tyler D., Mara, Arlind B., Goodridge, Meagan L., Ozyck, Rosemary Grace, Reinhardt, Emily, Miller, Jeremy M., Hunte, Morgan, Tulman, Edan R., Frasca Jr, Salvatore, Silbart, Lawrence K., Geary, Steven J., Szczepanek, Steven M.

    Published in npj vaccines (31-10-2022)
    “…Development of an effective vaccine for Mycoplasma pneumoniae has been hindered by reports of Vaccine Enhanced Disease (VED) in test subjects vaccinated and…”
    Get full text
    Journal Article
  10. 10

    Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease by Mara, Arlind B., Gavitt, Tyler D., Tulman, Edan R., Geary, Steven J., Szczepanek, Steven M.

    Published in npj vaccines (08-04-2020)
    “…Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent Mycoplasma pneumoniae . To date VED has prevented…”
    Get full text
    Journal Article
  11. 11

    B cells oppose M ycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs by Tyler D. Gavitt, Arlind B. Mara, Meagan L. Goodridge, Rosemary Grace Ozyck, Emily Reinhardt, Jeremy M. Miller, Morgan Hunte, Edan R. Tulman, Salvatore Frasca Jr, Lawrence K. Silbart, Steven J. Geary, Steven M. Szczepanek

    Published in npj vaccines (01-12-2022)
    “…Abstract Development of an effective vaccine for Mycoplasma pneumoniae has been hindered by reports of Vaccine Enhanced Disease (VED) in test subjects…”
    Get full text
    Journal Article
  12. 12

    B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs by Gavitt, Tyler D., Mara, Arlind B., Goodridge, Meagan L., Ozyck, Rosemary Grace, Reinhardt, Emily, Miller, Jeremy M., Hunte, Morgan, Tulman, Edan R., Frasca Jr, Salvatore, Silbart, Lawrence K., Geary, Steven J., Szczepanek, Steven M.

    Published in npj vaccines (31-10-2022)
    “…Development of an effective vaccine for Mycoplasma pneumoniae has been hindered by reports of Vaccine Enhanced Disease (VED) in test subjects vaccinated and…”
    Get full text
    Journal Article
  13. 13

    A CCL5 chemokine trail laid down by migratory dendritic cells directs CCR5 +antigen-presenting monocytes into draining lymph nodes by Rawat, Kavita, Tewari, Anita, Li, Xin, Mara, Arlind B, King, William T, Gibbings, Sophie L, Nnam, Chinaza F, Kolling, Fred B, Lambrecht, Bart N, Jakubzick, Claudia V

    Published in The Journal of immunology (1950) (01-05-2023)
    “…Antigen presenting dendritic cells (DCs) and monocytes capture and transport antigens from barrier tissues for presentation to antigen-specific T cells in the…”
    Get full text
    Journal Article
  14. 14

    Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease by Mara, Arlind B, Gavitt, Tyler D, Tulman, Edan R, Geary, Steven J, Szczepanek, Steven M

    Published in npj vaccines (08-04-2020)
    “…Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent Mycoplasma pneumoniae. To date VED has prevented…”
    Get full text
    Journal Article